| Product Code: ETC7312929 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Pharmacogenetic Testing Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Germany Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Germany Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Germany Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Germany Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing adoption of pharmacogenetic testing by healthcare providers |
4.2.3 Government initiatives promoting precision medicine in Germany |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for pharmacogenetic testing in Germany |
5 Germany Pharmacogenetic Testing Market Trends |
6 Germany Pharmacogenetic Testing Market, By Types |
6.1 Germany Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Germany Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Germany Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Germany Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Germany Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Germany Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Germany Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Germany Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Germany Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Germany Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Germany Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Germany Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Germany Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Germany Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Germany Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Germany Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Germany Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Germany Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Germany Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Germany Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Germany Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Germany Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Germany Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Germany Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Germany Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Germany Pharmacogenetic Testing Market Export to Major Countries |
7.2 Germany Pharmacogenetic Testing Market Imports from Major Countries |
8 Germany Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare facilities in Germany |
8.2 Number of clinical trials integrating pharmacogenetic testing in Germany |
8.3 Research and development investments in pharmacogenetic testing technologies |
9 Germany Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Germany Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Germany Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Germany Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Germany Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Germany Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here